Cancer latest info, news, treatment, advice- Mainstream and alternative cancer cures

γ-Tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways

British Journal of Cancer advance online publication, November 11, 2008. doi:10.1038/sj.bjc.6604763

Authors: W N Yap, P N Chang, H Y Han, D T W Lee, M T Ling, Y C Wong & Y L Yap

Antiangiogenic drugs in ovarian cancer

British Journal of Cancer advance online publication, November 11, 2008. doi:10.1038/sj.bjc.6604767

Authors: G C Kumaran, G C Jayson & A R Clamp

A longitudinal investigation of psychological morbidity in patients with ovarian cancer

British Journal of Cancer advance online publication, November 11, 2008. doi:10.1038/sj.bjc.6604770

Authors: V Gonçalves, G Jayson & N Tarrier

Concepts of epigenetics in prostate cancer development

British Journal of Cancer advance online publication, November 11, 2008. doi:10.1038/sj.bjc.6604771

Authors: C S Cooper & C S Foster

TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer

British Journal of Cancer advance online publication, November 11, 2008. doi:10.1038/sj.bjc.6604774

Authors: J F Knight, C J Shepherd, S Rizzo, D Brewer, S Jhavar, A R Dodson, C S Cooper, R Eeles, A Falconer, G Kovacs, M D Garrett, A R Norman, J Shipley & D L Hudson

Breast cancer incidence following low-dose rate environmental exposure: Techa River Cohort, 1956–2004

British Journal of Cancer advance online publication, November 11, 2008. doi:10.1038/sj.bjc.6604775

Authors: E Ostroumova, D L Preston, E Ron, L Krestinina, F G Davis, M Kossenko & A Akleyev

Radon and risk of extrapulmonary cancers: results of the German uranium miners' cohort study, 1960–2003

British Journal of Cancer advance online publication, November 11, 2008. doi:10.1038/sj.bjc.6604776

Authors: M Kreuzer, L Walsh, M Schnelzer, A Tschense & B Grosche

MAL promoter hypermethylation as a novel prognostic marker in gastric cancer

British Journal of Cancer advance online publication, November 11, 2008. doi:10.1038/sj.bjc.6604777

Authors: T E Buffart, R M Overmeer, R D M Steenbergen, M Tijssen, N C T van Grieken, P J F Snijders, H I Grabsch, C J H van de Velde, B Carvalho & G A Meijer

Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells

British Journal of Cancer advance online publication, November 11, 2008. doi:10.1038/sj.bjc.6604778

Authors: R K Singh, T S Lange, K K Kim, A P Singh, N Vorsa & L Brard

Emerging ethnic differences in lung cancer therapy

British Journal of Cancer advance online publication, November 4, 2008. doi:10.1038/sj.bjc.6604721

Authors: I Sekine, N Yamamoto, K Nishio & N Saijo

Two-marker protein profile predicts poor prognosis in patients with early rectal cancer

British Journal of Cancer advance online publication, November 4, 2008. doi:10.1038/sj.bjc.6604729

Authors: I Zlobec, K Baker, L Terracciano, S Peter, L Degen, C Beglinger & A Lugli

The T1799A point mutation is present in posterior uveal melanoma

British Journal of Cancer advance online publication, November 4, 2008. doi:10.1038/sj.bjc.6604731

Authors: C S Janssen, R Sibbett, F L Henriquez, I C McKay, E G Kemp & F Roberts

Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice

British Journal of Cancer advance online publication, November 4, 2008. doi:10.1038/sj.bjc.6604740

Authors: L Jin, A Burniat, J-E Dumont, F Miot, B Corvilain & B Franc

Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types

British Journal of Cancer advance online publication, November 4, 2008. doi:10.1038/sj.bjc.6604746

Authors: M H W Starmans, B Krishnapuram, H Steck, H Horlings, D S A Nuyten, M J van de Vijver, R Seigneuric, F M Buffa, A L Harris, B G Wouters & P Lambin

2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer

British Journal of Cancer advance online publication, November 4, 2008. doi:10.1038/sj.bjc.6604752

Authors: S L C Tagg, P A Foster, M P Leese, B V L Potter, M J Reed, A Purohit & S P Newman

FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer

British Journal of Cancer advance online publication, November 4, 2008. doi:10.1038/sj.bjc.6604753

Authors: M J Baker, E Gazi, M D Brown, J H Shanks, P Gardner & N W Clarke

High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability

British Journal of Cancer advance online publication, November 4, 2008. doi:10.1038/sj.bjc.6604756

Authors: S Michel, A Benner, M Tariverdian, N Wentzensen, P Hoefler, T Pommerencke, N Grabe, M von Knebel Doeberitz & M Kloor

Spatial variation in prostate cancer survival in the Northern and Yorkshire region of England using Bayesian relative survival smoothing

British Journal of Cancer advance online publication, November 4, 2008. doi:10.1038/sj.bjc.6604757

Authors: L Fairley, D Forman, R West & S Manda

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer

British Journal of Cancer advance online publication, November 4, 2008. doi:10.1038/sj.bjc.6604758

Authors: C McCowan, J Shearer, P T Donnan, J A Dewar, M Crilly, A M Thompson & T P Fahey

Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer

British Journal of Cancer advance online publication, November 4, 2008. doi:10.1038/sj.bjc.6604760

Authors: Y Y Cheng, H Jin, X Liu, J M T Siu, Y P Wong, E K O Ng, J Yu, W-k Leung, J J Y Sung & F K L Chan